New combo therapy aims to control advanced bladder cancer
NCT ID NCT07221942
Summary
This study is testing a two-part treatment for advanced bladder cancer that has spread. First, patients receive a combination of two drugs for about 4 months. If the cancer responds well, they then continue with just one of the drugs as a long-term 'maintenance' therapy for up to 2 years. The goal is to control the cancer and keep it from growing for as long as possible.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fox Chase Cancer Center - Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19111-2497, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.